FDA details blood clot risk on birth control pills
Washington: Federal health regulators said Tuesday they are adding labeling to Yaz and other newer birth control pills emphasizing that the drugs may be more likely to cause blood clots than older contraceptive pills.
The labeling will apply to Bayer`s Yaz, its predecessor Yasmin and similar drugs containing the manmade hormone called drospirenone, which mimics the naturally occurring female hormone progesterone. The drugs are among the best-selling contraceptives in the US, due to marketing emphasizing their ability to clear up acne and other hormone-related issues.
The FDA said the new labeling will detail recent studies suggesting drospirenone-containing pills carry a slightly higher risk of blood clots than other birth control pills. The risk of blood clots with either group of drugs is still very rare.
More from India
More from World
More from Sports
More from Entertaiment
- Jamaat-e-Islami chief announces Rs 100 cr reward for PM Modi's arrest
- DNA: Captain Saurabh Kalia's torture at the hands of Pakistani Army
- DNA: Govt tests Maggi noodle samples from all states
- Zee Media exclusive interview with victim of Uber molestation
- Jamaat-e-Islami chief announces Rs 1 billion reward for PM Modi's arrest
- Assam Board (seba.net.in & resultsassam.nic.in): SEBA HSLC / AHM class 10th Results 2015 to be announced today
- Was asked to call Sunanda Pushkar’s death `natural`: AIIMS doctor
- Maggi row: Delhi registers case against Nestle, Kerala withdraws stock from govt stores
- From being the ‘Dabangg’ girl to ‘Akira’ - Sonakshi Sinha’s journey so far
- China ship carrying 458 on board sinks in Yangtze River: Five dead, hundreds missing